The activation of the platelet is important for the hemostatic process, since the platelet thereby becomes a full participant in the formation of lesion-directed aggregates, a secretor of vasoconstricting and mitogenic substances, and a surface for the generation of pro-coagulant protein factors. It is now well recognized that the hydrolysis of a quantitatively minor species of phospholipid, phosphoinositide (PI), by phosphoinositidase C (PIC) is one of the major initial events that couples a cell surface-directed agonist to a full cellular response. Another agonist-induced change in platelet PI metabolism described recently is phosphorylation of PI species by a 3-kinase (PI-3K). This reaction, in nucleated cells, appears to be required for mitogenic responses. The function of the resulting PI's is as yet unknown, especially in the anucleate platelet. Since PI-3K products are poor substrates for PIC, they probably function directly, rather than as precursors for signals. Major phospholipid, such as phosphatidylcholine (PtdCho), serves as a reserve for the thromboxane A2 precursor, arachidonic acid (C20:4), which is liberated in activated platelets via phospholipase A (PLA). All of these changes appear to be controlled by G-proteins. In the course of platelet activation, amorphous cytoplasmic precursors polymerize into organized cytoskeleton, and glycoproteins change their linkage to membrane cytoskeleton. We intend to explore how the metabolic changes in PI's catalyzed by PIC and PI-3K and the mobilization of C20:4 are coordinated with alterations in the platelet cytoskeletal apparatus, temporally and functionally. Four additional activatable platelet components: tyrosine kinase, the thiol protease calpain, G-protein(s), and the integrin GPIIb/IIIa, will be investigated with respect to PIC, PI-3K and PIA regulation. Techniques for monitoring platelet PIC and PI-3K by radioisotopic and mass analysis in conjunction with thin layer chromatography (TLC) and HPLC were pioneered, and are in common use in, this lab. We also have demonstrated expertise in measuring C20:4 mobilization and PLA activation by TLC and HPLC. These techniques, in part, will be applied to triton-insoluble cytoskeletal and membrane skeletal preparations as well as to immunoprecipitated phosphotyrosine-containing protein. The effects of two PI-3K products on gelsolin and profilin function (modulating actin polymerization) will be measured. Activation of tyrosine kinase, G-protein, and calpain will be monitored by immunoblotting techniques and their function, as well as that of GPIIb/IIIa, will be perturbed with appropriate inhibitors and agonists and compared with alterations in PIC, PI-3K, and PLA activities.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038622-10
Application #
2218950
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1986-09-01
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Zhang, Jin; Vanhaesebroeck, Bart; Rittenhouse, Susan E (2002) Human platelets contain p110delta phosphoinositide 3-kinase. Biochem Biophys Res Commun 296:178-81
Jin, Jianguo; Quinton, Todd M; Zhang, Jin et al. (2002) Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood 99:193-8
Banfic, H; Tang, X; Batty, I H et al. (1998) A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets. J Biol Chem 273:13-6
Zhang, J; Banfic, H; Straforini, F et al. (1998) A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate. J Biol Chem 273:14081-4
Banfic, H; Downes, C P; Rittenhouse, S E (1998) Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:11630-7
Domin, J; Pages, F; Volinia, S et al. (1997) Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J 326 ( Pt 1):139-47
Abrams, C S; Zhang, J; Downes, C P et al. (1996) Phosphopleckstrin inhibits gbetagamma-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinase. J Biol Chem 271:25192-7
Zhang, J; Zhang, J; Shattil, S J et al. (1996) Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin. J Biol Chem 271:6265-72
Rittenhouse, S E (1996) Phosphoinositide 3-kinase activation and platelet function. Blood 88:4401-14
Zhang, J; Falck, J R; Reddy, K K et al. (1995) Phosphatidylinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets. J Biol Chem 270:22807-10

Showing the most recent 10 out of 34 publications